Business Context and Reporting Period
This Form 8-K reports the results of the Annual Meeting of Shareholders held by Anthem, Inc. on May 18, 2022. The filing documents the voting outcomes for director elections, executive compensation, auditor ratification, a corporate name change, and shareholder proposals.
Key Financial Metrics
This filing is a current report regarding corporate governance and shareholder voting. It does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data.
Material Changes
The most significant material change approved by shareholders is the amendment to the Company's Articles of Incorporation to change the corporate name from Anthem, Inc. to Elevance Health, Inc.
Outlook, Risks, and Voting Results
Shareholders approved the election of four directors (Susan D. DeVore, Bahija Jallal, Ryan M. Schneider, and Elizabeth E. Tallett) for three-year terms. The advisory vote on executive compensation was approved, and the appointment of Ernst & Young LLP as the independent auditor was ratified.
Two shareholder proposals were rejected:
- A proposal to prohibit political funding received approximately 4% support.
- A proposal requesting a racial impact audit received approximately 41% support.
Investor Verification Checklist
- Confirm the effective date of the name change to Elevance Health, Inc.
- Verify the ticker symbol update on the NYSE following the name change.
- Review the full proxy statement for details on the rejected shareholder proposals and the specific terms of the new directors.